| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/23/2005 | CA2548015A1 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544617A2 Use of a Nifie 14 binding substance for the diagnosis and treatment of cancer |
| 06/22/2005 | EP1544301A1 DNA molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544293A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 06/22/2005 | EP1544291A1 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof |
| 06/22/2005 | EP1544215A1 Human anti-idiotypic antibody fragments that mimic HER-2/neu |
| 06/22/2005 | EP1544214A1 Non-neutralizing anti-apc antibodies |
| 06/22/2005 | EP1544213A1 Use of ligands of the antigen cd52 for the treatment of solid tumours and bone-related cancerous diseases |
| 06/22/2005 | EP1544211A1 LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/22/2005 | EP1543839A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543166A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/22/2005 | EP1543038A2 Protein purification |
| 06/22/2005 | EP1543037A2 Dendritic cell pontentiation |
| 06/22/2005 | EP1543036A1 Protein for diagnosing diabetic retinopathy |
| 06/22/2005 | EP1543035A1 Monoclonal antibody derived peptide inhibitors for mycobacterial dna gyrase |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543033A1 Wnt mediated erbb signalling, compositions and uses related thereto |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1542731A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 06/22/2005 | EP1542725A2 Method of humanizing immune system molecules |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542721A1 Modified "s" antibodies |
| 06/22/2005 | EP1542720A2 Treatment of tnf alpha related disorders |
| 06/22/2005 | EP1542719A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | EP1542609A2 Methods for up-regulating antigen expression in tumors |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1483408A4 Nanostructures containing pna joining or functional elements |
| 06/22/2005 | EP1220944A4 Nuclease inhibitor cocktail |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP0870509B1 Sugar chain-recognizing antibody and remedy for infection with hiv |
| 06/22/2005 | EP0791066B1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP0670892B1 Purification, composition and specificity of heparinase i, ii, and iii from flavobacterium heparinum |
| 06/22/2005 | CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity |
| 06/22/2005 | CN1630708A Osteoclast-associated receptor |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630514A Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | CN1629291A A shrimp gene Intlp and polypeptides coded thereby |
| 06/22/2005 | CN1629290A A shrimp gene PIAV and polypeptides coded thereby |
| 06/22/2005 | CN1629189A Specific antigen of Japanese blood fluke and its use |
| 06/22/2005 | CN1629188A Specific antigen of Japanese blood fluke and its use |
| 06/22/2005 | CN1207387C Polypeptides and genes encoding same |
| 06/22/2005 | CN1207057C Anti-sphagitis specificity composite IgY and preparation thereof |
| 06/21/2005 | US6908994 Collagen-binding proteins from enterococcal bacteria |
| 06/21/2005 | US6908988 Animal models; medical diagnosis; antitumor agents |
| 06/21/2005 | US6908750 Gene encoding HM1.24 antigen protein and promoter thereof |
| 06/21/2005 | US6908734 Sulfated CCR5 peptides for HIV-1 infection |
| 06/21/2005 | US6908616 Composition suitable for immunizing crustaceans by injection against White Spot Syndrome Virus, WSSV, comprising isolated protein consisting of specified amino acid sequence, which delays mortality against WSSV infectivity in crustaceans |
| 06/21/2005 | US6908613 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/21/2005 | US6908612 Virus coat protein/receptor chimeras and methods of use |
| 06/21/2005 | CA2145005C Monoclonal antibodies specific for tcf-ii |
| 06/21/2005 | CA2044421C Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/19/2005 | CA2494572A1 Cytochrome p450 24 (cyp24) monoclonal antibody and methods and uses thereof |
| 06/16/2005 | WO2005054868A1 Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases |
| 06/16/2005 | WO2005054509A2 Assay and treatment |
| 06/16/2005 | WO2005054499A2 Use of l-isoaspartyl methyltransferase as longevity marker in seeds |
| 06/16/2005 | WO2005054469A1 Anti-sars monoclonal antibodies |
| 06/16/2005 | WO2005054465A1 Method of obtaining gene tag |
| 06/16/2005 | WO2005054434A2 Use of notch pathway interfering agents for treatment of plasma cell disorders |
| 06/16/2005 | WO2005054427A2 Target sequences for synthetic molecules |
| 06/16/2005 | WO2005054296A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 06/16/2005 | WO2005054295A2 Therapeutic and diagnostic anti-hsp 70 antibodies |
| 06/16/2005 | WO2005054294A2 Inhibitors of glycoprotein vi based on monoclonal antibody hgp 5c4 |
| 06/16/2005 | WO2005054290A2 Peptide hormones zalpha48 and zsig97 |
| 06/16/2005 | WO2005054273A2 Humanized antibodies against vascular endothelial growth factor |
| 06/16/2005 | WO2005053742A1 Medicine containing antibody composition |
| 06/16/2005 | WO2005053741A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 06/16/2005 | WO2005053726A1 Selective neuropeptide y2 receptor agonists |
| 06/16/2005 | WO2005053604A2 Antibodies specific for cancer associated antigen sm5-1 and uses thereof |
| 06/16/2005 | WO2005044293A3 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 06/16/2005 | WO2005042578A3 Antibody fab fragment specific for breast cancer |
| 06/16/2005 | WO2005041877A3 Method of inhibiting rejection following organ transplantation |
| 06/16/2005 | WO2005040386A3 A vector modification for versatile use of expressed products |
| 06/16/2005 | WO2005037869A3 Method of reducing leachate from protein a affinity media |
| 06/16/2005 | WO2005033144A3 Tim-3 polypeptides |
| 06/16/2005 | WO2005032589A8 Prevention and treatment for gvhd |
| 06/16/2005 | WO2005026211A3 Anti-ghrelin antibodies |
| 06/16/2005 | WO2005024032A3 Targeting adenoviral vectors to dendritic cells |
| 06/16/2005 | WO2005021594A3 Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use |
| 06/16/2005 | WO2005018571A3 Compositions and methods for treating inflammatory lung disease |
| 06/16/2005 | WO2005017179A3 Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same |
| 06/16/2005 | WO2005014653A3 Humanized chicken antibodies |
| 06/16/2005 | WO2005014645A3 Pedf-r receptor and uses |
| 06/16/2005 | WO2005013899A9 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/16/2005 | WO2005010167A3 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 06/16/2005 | WO2005004800A3 Trypanosome derived apoptotic factors (taf) |
| 06/16/2005 | WO2005003154A8 Compositions and methods for the diagnosis and treatment of tumor |
| 06/16/2005 | WO2005001048A3 Preparation and application of anti-tumor bifunctional fusion proteins |
| 06/16/2005 | WO2004106367A3 Enterococcus antigens |
| 06/16/2005 | WO2004094476A3 Compositions and methods relating to stop-1 |
| 06/16/2005 | WO2004084816A3 IMPROVED CD4-IgG2 FORMULATIONS |